News
India's Pharma Sector Transformation Drives Self-Reliance, Boosts Economy: Minister Singh
India's pharmaceutical and medical technology sectors are experiencing a significant shift towards self-reliance, according to Union Minister Jitendra Singh. This evolution is expected to substantially contribute to the country's GDP and establish India as a key global hub.
Speaking at a healthcare summit in New Delhi, Union Minister of State for Science and Technology Jitendra Singh said that India's healthcare system is undergoing a major transformation with a focus on global quality standards and integrating research with industry. Singh noted India's move from import dependence to prioritizing domestic capabilities in healthcare. Critical medical resources once primarily sourced internationally, making treatments costly, are now being developed within India, according to Singh. India's ability to produce its own antibiotics, vaccines and advanced treatments signifies a move towards self-sufficiency, Singh stated. Singh cited India's vaccine supply to other countries during the COVID-19 pandemic as evidence of its growing role as a global healthcare partner. Singh said this transformation will accelerate economic growth.
Key Facts
- Jitendra Singh, Union Minister, reports India's growing strength in pharma and medical technology.
- Singh says the national healthcare system is undergoing a major shift.
- The transition prioritizes global quality benchmarks and industry-research integration.
- India is shifting from import reliance to domestic production of medicines and devices.
- India is now producing its own antibiotics, vaccines and advanced therapies.
- India's vaccine supply during COVID-19 pandemic reinforced its global healthcare role.
- The Minister said the transformation will accelerate economic growth and GDP contribution.
Primary Source
Research Sources
- Asian News International (ANI) — India's MedTech, Pharma boom sign of shift to self-reliant healthcare growth: Jitendra Singh